Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Computational Model Accurately Simulates Shunt Performance to Prevent Repeat Surgeries

By HospiMedica International staff writers
Posted on 24 Jul 2025

Millions of people worldwide suffer from hydrocephalus, a condition characterized by the buildup of excess cerebrospinal fluid in the brain. More...

Treatment typically involves the surgical placement of shunts to divert the fluid, but this approach often leads to complications, including infections and repeated procedures. Tens of thousands of shunt surgeries are performed each year in the U.S. alone, with many patients requiring repeat surgeries due to obstruction or infection. These issues are often tied to the fact that conventional shunt tubing mimics household plumbing, lacking consideration for the brain’s complex fluid dynamics. Now, researchers have developed a new computational model that simulates shunt performance by integrating brain anatomy, fluid flow, and biomolecular transport, to enable custom shunt designs tailored to individual patients.

The model named BrainFlow was developed by researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences (Cambridge, MA, USA) after they recognized the absence of a universally accepted fluid flow model for the brain’s ventricular space. BrainFlow combines detailed anatomical and physiological features of the brain to simulate the flow of cerebrospinal fluid in the presence of shunt implants. It incorporates patient-specific medical imaging and mimics pulse-induced flow to reflect realistic cerebrospinal fluid dynamics. This allows for insights into optimal shunt design, placement, and materials.

In their study published in the Proceedings of the National Academy of Sciences, the researchers pursued the problem from both a design and material science perspective, considering biomimetic solutions and anti-biofouling coatings to reduce the risk of complications. The team is now using the BrainFlow model to test various shunt designs and calculate their performance efficacy. By providing detailed simulations, the model could lead to smoother integration of optimized, patient-specific devices into the brain, reducing complications and enhancing quality of life. Looking ahead, the researchers plan to further evaluate the model’s accuracy in predicting long-term outcomes and refine it for broader clinical use.

“We believe that our model, combined with novel geometries and materials improvements such as anti-biofouling coatings developed in my lab, could lead to smoother integration of optimized, patient-specific medical devices into patients’ brains, with less likelihood of complications, and a better quality of life,” said SEAS Professor Joanna Aizenberg.

Related Links:
Harvard SEAS


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.